There have been several previous publications describing the association of LIN28B—usually in primary tumors—with adverse outcomes in other cancer types, including hepatocellular carcinoma42, oral squamous cell carcinoma43, breast cancer44, acute myeloid leukemia45, and multiple myeloma46. Here, LIN28B is linked to cancer.